Get started
Author

Gerardo Huidobro

Observed names: G Huidobro, G. Huidobro, GERARDO HUIDOBRO, Gerardo Huidobro Vence
Observed institutions: Hospital de Sant Pau, University Hospital Complex Of Vigo, Complejo Hospitalario Universitario de Santiago, Centro Oncológico de Galicia, Hospital de Sagunto, Puigvert Foundation, Hospital Xeral Calde, Complejo Hospitalario de Pontevedra, Complejo Hospitalario de Ourense
ORCID: 0000-0002-9167-6502
Observed ORCID: 0000-0002-9167-6502
OpenAlex ID: A5006579116
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
2023 · Ernest Nadal, Delvys Rodríguez-Abreu, et al. · Journal of Clinical Oncology · 126
PDF
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
2021 · Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, et al. · Clinical and Translational Medicine · 53
Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment
2007 · C. Grande, M. J. Villanueva, et al. · Clinical & Translational Oncology · 49
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy
1997 · M. Hidalgo, L. Paz-Ares, et al. · Annals of Oncology · 33
Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia.
1994 · J Nomdedéu, R Martino, et al. · PubMed · 19
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer
2024 · Melina Peressini, Rosario Garcia-Campelo, et al. · Clinical Cancer Research · 18
Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
2004 · Sergio Vázquez, Carlos Grande, et al. · Anti-Cancer Drugs · 18
OA09.02 Atezo-Brain: Single Arm Phase II Study of Atezolizumab Plus Chemotherapy in Stage IV NSCLC With Untreated Brain Metastases
2021 · E. Nadal, B. Massuti, et al. · Journal of Thoracic Oncology · 14
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study
2013 · J. Casal Rubio, J. L. Fírvida-Pérez, et al. · Cancer Chemotherapy and Pharmacology · 13
A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma
2009 · As representatives of the Galician Group of Lung Cancer (GGCP in the Spanish acronym), Joaquín Casal Rubio, et al. · Cancer Chemotherapy and Pharmacology · 13
Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group
2003 · L León, Juan F Cueva-Banuelos, et al. · Lung Cancer · 12
Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial)
2025 · Belén Sierra Rodero, Cristina Martínez-Toledo, et al. · OncoImmunology · 10
PDF
OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG
2018 · M. Provencio, E. Nadal, et al. · Journal of Thoracic Oncology · 9
Phase II Study of Weekly Irinotecan (CPT-11) as Second-Line Treatment of Patients with Advanced Colorectal Cancer
2003 · J. Cassinello, P. López-Alvarez, et al. · Medical Oncology · 7
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
2023 · SANTIAGO AGUIN, ALBERTO CARRAL, et al. · Cancer Diagnosis & Prognosis · 5
PDF
Induction chemotherapy with taxol (T), cisplatin (C) and gemcitabine (G) and subsequent radiation therapy with or without concomitant taxol for stage III non small cell lung cancer (nsclc). a galician lung cancer group (GLGC) study
2001 · J. Casal, J. Fírvida, et al. · European Journal of Cancer · 4
Real-world clinical experience with osimertinib in advanced EGFR-mutated non-small cell lung cancer
2025 · María Carmen Areses Manrique, Luis León-Mateos, et al. · Clinical & Translational Oncology · 3
Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
2019 · R. Laza-Briviesca, A. Cruz-Bermudez, et al. · Annals of Oncology · 3
1155 A phase III trial of neoadjuvant chemotherapy (NCT) in patients (PTS) with invasive bladder cancer (IBC). Preliminary results: NCT improves pathological complete response rate
1995 · E. Marcuello, J.M. Tabernero, et al. · European Journal of Cancer · 3
Phase II study of biweekly XELOX (capecitabine and oxaliplatin) as first line chemotherapy in elderly patients with metastatic colorectal cancer
2009 · C. Grande, G. Quintero, et al. · Journal of Clinical Oncology · 2
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)
2007 · Sergio Vázquez, Gerardo Huidobro, et al. · Anti-Cancer Drugs · 2
Multicenter phase II study of cetuximab and irinotecan as third line chemotherapy in patients (pts) with metastatic colorectal cancer (MCRC) previously treated with both irinotecan and oxaliplatin regimens
2006 · C. Grande, J. R. Mel, et al. · Journal of Clinical Oncology · 2
P3.18.12 ARIAN, Adjuvant Treatment With Sacituzumab and ZimberelimAb in Resected Patients: A Phase III Study - Trial in Progress
2025 · M. Provencio, D. Aguiar, et al. · Journal of Thoracic Oncology · 1
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
2025 · LETICIA IGLESIAS, ROCÍO VÍLCHEZ, et al. · Anticancer Research · 1
FP12.09 Molecular Insight into NADIM Clinical Trial: Potential Immune Biomarkers of Pathological Response for NSCLC Patients.
2021 · R. Laza Briviesca, E. Nadal, et al. · Journal of Thoracic Oncology · 1
PDF
Works count: 59
Citation count: 426
H-index: 11
I10-index: 12
Year
Topic
Type